Spermine oxidase SMO(PAOh1), not N1-acetylpolyamine oxidase PAO, is the primary source of cytotoxic H2O2 in polyamine analogue-treated human breast cancer cell lines

被引:96
作者
Pledgie, A
Huang, Y
Hacker, A
Zhang, Z
Woster, PM
Davidson, NE
Casero, RA
机构
[1] Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21231 USA
[2] Wayne State Univ, Coll Pharm & Allied Hlth Profess, Dept Pharmaceut Sci, Detroit, MI 48202 USA
关键词
D O I
10.1074/jbc.M508177200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The induction of polyamine catabolism and its production of H2O2 have been implicated in the response to specific antitumor polyamine analogues. The original hypothesis was that analogue induction of the rate-limiting spermidine/spermine N-1-acetyltransferase (SSAT) provided substrate for the peroxisomal acetylpolyamine oxidase (PAO), resulting in a decrease in polyamine pools through catabolism, oxidation, and excretion of acetylated polyamines and the production of toxic aldehydes and H2O2. However, the recent discovery of the inducible spermine oxidase SMO(PAOh1) suggested the possibility that the original hypothesis may be incomplete. To examine the role of the catabolic enzymes in the response of breast cancer cells to the polyamine analogue N-1, N(1-)bis(ethyl) norspermine (BENSpm), a stable knockdown small interfering RNA strategy was used. BENSpm differentially induced SSAT and SMO(PAOh1) mRNA and activity in several breast cancer cell lines, whereas no N-1-acetylpolyamine oxidase PAO mRNA or activity was detected. BENSpm treatment inhibited cell growth, decreased intracellular polyamine levels, and decreased ornithine decarboxylase activity in all cell lines examined. The stable knockdown of either SSAT or SMO(PAOh1) reduced the sensitivity of MDA-MB-231cells to BENSpm, whereas double knockdown MDA-MB-231 cells were almost entirely resistant to the growth inhibitory effects of the analogue. Furthermore, the H2O2 produced through BENSpm-induced polyamine catabolism was found to be derived exclusively from SMO(PAOh1) activity and not through PAO activity on acetylated polyamines. These data suggested that SSAT and SMO(PAOh1) activities are the major mediators of the cellular response of breast tumor cells to BENSpm and that PAO plays little or no role in this response.
引用
收藏
页码:39843 / 39851
页数:9
相关论文
共 40 条
[1]   Oxidants and Antioxidants in Breast Cancer [J].
Ambrosone, Christine B. .
ANTIOXIDANTS & REDOX SIGNALING, 2000, 2 (04) :903-918
[2]   Novel synthetic polyamines are effective in the treatment of experimental microsporidiosis, an opportunistic AIDS-Associated infection [J].
Bacchi, CJ ;
Weiss, LM ;
Lane, S ;
Frydman, B ;
Valasinas, A ;
Reddy, V ;
Sun, JS ;
Marton, LJ ;
Khan, IA ;
Moretto, M ;
Yarlett, N ;
Wittner, M .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (01) :55-61
[3]   Mouse spermine oxidase:: a model of the catalytic cycle and its inhibition by N,N1-bis(2,3-butadienyl)-1,4-butanediamine [J].
Bellelli, A ;
Cavallo, S ;
Nicolini, L ;
Cervelli, M ;
Bianchi, M ;
Mariottini, P ;
Zelli, M ;
Federico, R .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2004, 322 (01) :1-8
[4]  
Berchtold CM, 1998, J CELL PHYSIOL, V174, P380, DOI 10.1002/(SICI)1097-4652(199803)174:3<380::AID-JCP12>3.0.CO
[5]  
2-D
[6]   SYNTHETIC POLYAMINE ANALOGS AS ANTINEOPLASTICS [J].
BERGERON, RJ ;
NEIMS, AH ;
MCMANIS, JS ;
HAWTHORNE, TR ;
VINSON, JRT ;
BORTELL, R ;
INGENO, MJ .
JOURNAL OF MEDICINAL CHEMISTRY, 1988, 31 (06) :1183-1190
[7]   N-2,3-BUTADIENYL-1,4-BUTANEDIAMINE DERIVATIVES - POTENT IRREVERSIBLE INACTIVATORS OF MAMMALIAN POLYAMINE OXIDASE [J].
BEY, P ;
BOLKENIUS, FN ;
SEILER, N ;
CASARA, P .
JOURNAL OF MEDICINAL CHEMISTRY, 1985, 28 (01) :1-2
[8]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[9]   Terminally alkylated polyamine analogues as chemotherapeutic agents [J].
Casero, RA ;
Woster, PM .
JOURNAL OF MEDICINAL CHEMISTRY, 2001, 44 (01) :1-26
[10]   The role of polyamine catabolism in anti-tumour drug response [J].
Casero, RA ;
Wang, Y ;
Stewart, TM ;
Devereux, W ;
Hacker, A ;
Wang, Y ;
Smith, R ;
Woster, PM .
BIOCHEMICAL SOCIETY TRANSACTIONS, 2003, 31 :361-365